[MYGN] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 10.63%
YoY- 65.71%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 160,800 167,300 189,400 173,100 154,600 145,200 93,200 43.70%
PBT -43,500 39,800 -3,800 -49,600 -55,700 -43,700 -58,500 -17.87%
Tax -35,900 15,200 900 -10,100 -11,500 -28,500 -3,000 420.81%
NP -7,600 24,600 -4,700 -39,500 -44,200 -15,200 -55,400 -73.30%
Tax Rate - -38.19% - - - - - -
Total Cost 168,400 142,700 194,100 212,600 198,800 160,400 148,600 8.67%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -4.73 14.70 -2.48 -22.82 -28.59 -10.47 -59.44 -81.41%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -0.10 0.31 -0.06 -0.52 -0.59 -0.20 -0.74 -73.57%
EPS Diluted -0.10 0.30 -0.06 -0.52 -0.59 -0.20 -0.74 -73.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.